wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q55251974-F62DEFF7-364D-4FE9-80CC-18787F41A213
Q55251974-F62DEFF7-364D-4FE9-80CC-18787F41A213
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55251974-F62DEFF7-364D-4FE9-80CC-18787F41A213
Baricitinib in Patients with Rheumatoid Arthritis and an Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs in United States and Rest of World: A Subset Analysis.
P2860
Q55251974-F62DEFF7-364D-4FE9-80CC-18787F41A213
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55251974-F62DEFF7-364D-4FE9-80CC-18787F41A213
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
61841ec6dd57d6bbf409b1bbe326f3ef1ada2350
P2860
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.